Viemed HEALTHCARE, Inc. (VMD) intrinsic value & 10-year financials

Viemed HEALTHCARE, Inc. (VMD) has a Graham intrinsic value of $6.79 per share. At $9.48 on Oct 17, 2026, the stock trades 40% above that value. Over the last 9 fiscal years revenue grew 22.7% a year to $270.3M, with an average return on invested capital of 22.6%.

Graham intrinsic value
$6.79
Share price (Oct 17, 2026)
$9.48
Price vs Graham value
40% above
Market cap
$387.0M
Revenue (FY2025)
$270.3M
Revenue growth (9-yr CAGR)
22.7%
ROIC (10-yr avg)
22.6%
Free cash flow (FY2025)
$11.9M

VMD 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $270.3M $14.9M $0.37 $11.9M 8.5% 12.2%
FY2024 $224.3M $11.3M $0.28 $1.3M 8.0% 10.9%
FY2023 $183.0M $10.2M $0.25 $19.1M 7.8% 10.7%
FY2022 $138.8M $6.2M $0.16 $4.8M 5.9% 7.5%
FY2021 $117.1M $9.1M $0.22 $2.8M 9.9% 12.9%
FY2020 $131.3M $31.5M $0.78 $22.1M 20.4% 54.6%
FY2019 $80.3M $8.5M $0.21 $5.7M 10.9% 27.4%
FY2018 $64.5M $9.5M $0.24 $16.3M 15.6% 44.6%
FY2017 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

VIEMED HEALTHCARE, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

VIEMED HEALTHCARE, INC. has earned high returns on invested capital, averaging 22.6% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

VIEMED HEALTHCARE, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, VIEMED HEALTHCARE, INC. is modeled at 6.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $6.79 per share.

VMD stock: frequently asked questions

What is the intrinsic value of Viemed HEALTHCARE, Inc. (VMD) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 6.4% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, VMD's intrinsic value is about $6.79 per share.

Is VMD stock undervalued?

At $9.48 (close on Oct 17, 2026), VMD trades 40% above its Graham value of $6.79. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

Does Viemed HEALTHCARE, Inc. generate free cash flow?

Viemed HEALTHCARE, Inc. generated $11.9M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 8 of the last 8 reported years.

What is VMD's return on invested capital?

Average ROIC over the last 9 fiscal years was 22.6%, and average return on equity was 19.3%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this VMD data come from?

From Viemed HEALTHCARE, Inc.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar misc health & allied services stocks